# CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial

> **NCT03455725** · NA · ACTIVE_NOT_RECRUITING · sponsor: **BioCardia, Inc.** · enrollment: 343 (estimated)

## Conditions studied

- Refractory Angina
- Chronic Myocardial Ischemia

## Interventions

- **DEVICE:** CardiAMP Cell Therapy System
- **OTHER:** Sham Treatment

## Key facts

- **NCT ID:** NCT03455725
- **Lead sponsor:** BioCardia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-30
- **Primary completion:** 2025-02-19
- **Final completion:** 2027-12
- **Target enrollment:** 343 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03455725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03455725, "CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03455725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*